Allspring Global Investments’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-119
| Closed | -$1.93K | – | 2273 |
|
|
2024
Q3 | $1.93K | Buy |
+119
| New | +$1.93K | ﹤0.01% | 2263 |
|
|
2023
Q4 | – | Sell |
-10,507
| Closed | -$113K | – | 2640 |
|
|
2023
Q3 | $113K | Buy |
10,507
+2,353
| +29% | +$25.4K | ﹤0.01% | 1948 |
|
|
2023
Q2 | $105K | Sell |
8,154
-685
| -8% | -$8.84K | ﹤0.01% | 2028 |
|
|
2023
Q1 | $117K | Buy |
8,839
+1,846
| +26% | +$24.4K | ﹤0.01% | 1985 |
|
|
2022
Q4 | $105K | Buy |
6,993
+3,499
| +100% | +$52.5K | ﹤0.01% | 2054 |
|
|
2022
Q3 | $41K | Buy |
3,494
+1,842
| +112% | +$21.6K | ﹤0.01% | 2418 |
|
|
2022
Q2 | $18K | Sell |
1,652
-23,060
| -93% | -$251K | ﹤0.01% | 2507 |
|
|
2022
Q1 | $738K | Sell |
24,712
-4,721
| -16% | -$141K | ﹤0.01% | 2053 |
|
|
2021
Q4 | $779K | Buy |
+29,433
| New | +$779K | ﹤0.01% | 2088 |
|